• Home
  • Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data.

Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data.

Author List
Li KD, Carlisle MN, Jarosek S, Patel HV, Faris A, Elliott SP, Cooperberg MR, Carroll PR, Breyer BN
Publication
European urology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/616353870
Publication Year
2025
PubMed ID
40410019
Publication Title
Li KD, Carlisle MN, Jarosek S, Patel HV, Faris A, Elliott SP, Cooperberg MR, Carroll PR, Breyer BN. Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data. Eur Urol. 2026 Jan; 89(1):8-11.
Publication Medline TA
Eur Urol
Date
2025-05-22